Circulating Cell-Free DNA Correlates with Body Integral Dose and Radiation Modality in Prostate Cancer

PURPOSE: The RadTox assay measures circulating cell-free DNA released in response to radiotherapy (RT)-induced tissue damage. The primary objectives for this clinical trial were to determine whether cell-free DNA numbers measured by the RadTox assay are (1) correlated with body integral dose, (2) lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lockney, Natalie A., Henderson, Randal, Swarts, Steven G., Zhang, Zhenhuan, Zhang, Bingrong, Li, Jennifer, Zlotecki, Robert A., Morris, Christopher G., Casey-Sawicki, Katherine, Okunieff, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Particle Therapy Co-operative Group 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707322/
https://www.ncbi.nlm.nih.gov/pubmed/33274254
http://dx.doi.org/10.14338/IJPT-20-00033.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707322/
https://www.ncbi.nlm.nih.gov/pubmed/33274254
http://dx.doi.org/10.14338/IJPT-20-00033.1

Ejemplares similares